Clinical Trial Update: A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene [Phase 2]

View source ↗

Summary

Phase 2 trial assessing enclosmiphene (12.5 mg or 25 mg) added to diet/exercise for men with acquired hypogonadotropic hypogonadism, focusing on body compositio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hypogonadotropic Hypogonadism
• Obesity

Drugs mentioned

• Enclomiphene (enclomiphene)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Acquired Hypogonadotropic Hypogonadism, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2019-06-14